Glucotrack Strengthens Leadership Team with New VP of Clinical Operations
Glucotrack, Inc. (Nasdaq: GCTK) is enhancing its leadership team by appointing Sandie Martha as the new Vice President of Clinical Operations. This strategic decision aims to improve the Company's clinical trial capabilities for its continuous blood glucose monitor, ultimately providing better support for individuals living with diabetes.
Extensive Expertise in Clinical Trials
With over 20 years of experience in clinical research, Sandie Martha has a rich background in both medical technology and drug development. Her expertise includes leading various phases of clinical trials, from protocol development to execution and training. She has a remarkable history of successfully guiding projects through the intricate clinical lifecycle.
Previous Experience and Achievements
Prior to joining Glucotrack, Ms. Martha held the position of Vice President of Clinical Affairs at Glysens, where she was responsible for the planning and execution of clinical trials for an innovative implantable continuous glucose monitor. This role highlighted her capability to advance glucose-monitoring technologies.
Dedication to Advancing Diabetes Management
Ms. Martha's career also encompasses significant clinical operations roles at renowned organizations such as Dexcom and Intersection Medical. These experiences have provided her with valuable insights into the challenges of diabetes management. She earned her Master of Science in Physiology from San Diego State University and her Bachelor of Science in Biological Sciences from the University of Miami.
Responsibilities in Her New Role
As the new Vice President at Glucotrack, Ms. Martha will be in charge of executing the Company’s Clinical Trial Program. Her responsibilities include working closely with Contract Research Organizations (CROs), clinical centers, and investigators while developing detailed clinical protocols. She will also oversee data collection, analysis, and reporting for regulatory submissions.
Passion for Enhancing Diabetes Management
Ms. Martha shared her motivation, stating, "Having witnessed loved ones struggle with their diabetes management, I am passionate about the potential of advanced glucose monitoring technologies. The real-time continuous blood glucose data provided by Glucotrack's CBGM offers a less intrusive approach, significantly improving the quality of life for those with diabetes. I am thrilled to join the Glucotrack leadership team to help bring this innovative technology to market."
About Glucotrack, Inc.
Founded to focus on the design, development, and commercialization of groundbreaking diabetes management technologies, Glucotrack, Inc. (NASDAQ: GCTK) is currently working on a long-term implantable continuous blood glucose monitoring system aimed at enhancing the lives of individuals with diabetes.
Continuous Blood Glucose Monitoring System
The Glucotrack CBGM is engineered to continuously measure blood glucose levels using a sensor designed to last over two years. This system does not require on-body wear and operates with minimal calibration, ensuring a smooth experience for users.
Contact Information for the Company
For inquiries and additional information about Glucotrack’s innovative solutions for diabetes management, interested parties can reach out via email:
Investor Relations:
investors@glucotrack.com
Media:
GlucotrackPR@icrinc.com
Frequently Asked Questions
What is the role of Sandie Martha at Glucotrack?
Sandie Martha serves as the Vice President of Clinical Operations, where she leads the company's Clinical Trial Program and manages clinical studies.
What is the Glucotrack Continuous Blood Glucose Monitor?
The Glucotrack CBGM is a long-term, implantable system designed to continuously measure blood glucose levels with minimal calibration, offering users an advanced monitoring solution.
Why is continuous glucose monitoring important?
Continuous glucose monitoring provides real-time data, enabling individuals with diabetes to manage their condition more effectively and enhance their quality of life.
What is Sandie Martha's experience in the clinical field?
Sandie Martha has over 20 years of experience in clinical research, focusing on medical technology and drug development, with a strong background in leading clinical trials.
How does Glucotrack contribute to diabetes management?
Glucotrack develops innovative technologies that assist individuals in managing their diabetes more effectively, aiming to alleviate the challenges associated with traditional glucose monitoring methods.
